CytoGen, Inc. (217330) Price & Analysis

― Followers

217330 Stock Chart & Stats

₩3065.00

₩10.00(0.33%)

Sep 08, 2026

―

Day’s Range― - ―

52-Week Range₩2,260.00 - ₩11,200.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)61.17K

Market Cap

₩70.48B

Enterprise Value₩65.07K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.33

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-95.01

Shares Outstanding23,129,547

10 Day Avg. Volume53,717

30 Day Avg. Volume61,169

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

217330 FAQ

What was CytoGen, Inc.’s price range in the past 12 months?

CytoGen, Inc. lowest stock price was ₩2260.00 and its highest was ₩11200.00 in the past 12 months.

What is CytoGen, Inc.’s market cap?

CytoGen, Inc.’s market cap is ₩70.48B.

When is CytoGen, Inc.’s upcoming earnings report date?

CytoGen, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 63 days.

How were CytoGen, Inc.’s earnings last quarter?

CytoGen, Inc. released its earnings results on Aug 13, 2026. The company reported -₩95.009 earnings per share for the quarter.

Is CytoGen, Inc. overvalued?

According to Wall Street analysts CytoGen, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does CytoGen, Inc. pay dividends?

CytoGen, Inc. does not currently pay dividends.

What is CytoGen, Inc.’s EPS estimate?

CytoGen, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does CytoGen, Inc. have?

CytoGen, Inc. has 23,129,547 shares outstanding.

What happened to CytoGen, Inc.’s price movement after its last earnings report?

CytoGen, Inc. reported an EPS of -₩95.009 in its last earnings report. Following the earnings report the stock price went down -0.687%.

Which hedge fund is a major shareholder of CytoGen, Inc.?

Currently, no hedge funds are holding shares in KR:217330

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology